Aironax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-06-2024
- Paid Up Capital ₹ 20.00 K
as on 22-06-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.08%
(FY 2022)
- Profit 30.50%
(FY 2022)
- Ebitda 1149.15%
(FY 2022)
- Net Worth 76.66%
(FY 2022)
- Total Assets 34.86%
(FY 2022)
About Aironax Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 20.00 K , as per Ministry of Corporate Affairs (MCA) records.
Jaya Sriwastava, Vijay Srivastava, and Vivek Shrivastav serve as directors at the Company.
- CIN/LLPIN
U24239GJ2019PTC107343
- Company No.
107343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2019
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aironax Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaya Sriwastava  | Additional Director | 20-Jun-2019 | Current |
| Vijay Srivastava | Director | 29-Mar-2019 | Current |
| Vivek Shrivastav | Director | 29-Mar-2019 | Current |
Financial Performance of Aironax Pharmaceuticals.
Aironax Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.08% increase. The company also saw a substantial improvement in profitability, with a 30.5% increase in profit. The company's net worth Soared by an impressive increase of 76.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aironax Pharmaceuticals?
Unlock access to Aironax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aironax Pharmaceuticals?
Unlock and access historical data on people associated with Aironax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aironax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aironax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
